Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.

<h4>Aim</h4>In United Arab Emirates, cardiovascular disease (CVD) is a leading cause of mortality and 22% of CVD deaths are attributable to acute myocardial infarction (MI). Adherence to guidelines for lipid management is incompletely described in the Middle East. This study aimed to cha...

Full description

Bibliographic Details
Main Authors: Lionel Pinto, Mohamed Farghaly, Sasikiran Nunna, Badarinath Chickballapur Ramachandrachar, Sri Harshadeep Chilukuri, Ashok Natarajan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0268709
_version_ 1828111978912022528
author Lionel Pinto
Mohamed Farghaly
Sasikiran Nunna
Badarinath Chickballapur Ramachandrachar
Sri Harshadeep Chilukuri
Ashok Natarajan
author_facet Lionel Pinto
Mohamed Farghaly
Sasikiran Nunna
Badarinath Chickballapur Ramachandrachar
Sri Harshadeep Chilukuri
Ashok Natarajan
author_sort Lionel Pinto
collection DOAJ
description <h4>Aim</h4>In United Arab Emirates, cardiovascular disease (CVD) is a leading cause of mortality and 22% of CVD deaths are attributable to acute myocardial infarction (MI). Adherence to guidelines for lipid management is incompletely described in the Middle East. This study aimed to characterize lipid lowering therapy (LLT) patterns and the risk of subsequent cardiovascular events (CVEs) in the first year after MI.<h4>Methods</h4>This was a retrospective cohort study using the Dubai Real-World Claims Database, including all patients discharged with MI between January 01, 2015 and December 31, 2018, followed-up until December 31, 2019.<h4>Results</h4>In the first year after MI, 8.42% of 4,595 patients included experienced at least one recurrent MI (rate 6.77 events/100 person-years [PYs]), 2.94% had one revascularization (cumulative rate 0.55 events/100 PYs) and 2.66% had one hospitalization due to unstable angina (cumulative rate 5.16 new events/100 PYs). The majority (60.40%) of the patients presented with LDL-C levels ≥ 70 mg/dL after MI. In the first year after MI, 93.45% of the patients received LLT, mainly high-intensity statin (67.79%); with a minority of patients receiving statin + ezetimibe (4.55%), PCSK9i (0.20%) or ezetimibe alone (0.07%).<h4>Conclusion</h4>Patients hospitalized with MI in Dubai present an increased risk of CVEs in their first-year post-discharge. Majority of the patients presented with LDL-C levels above 70 mg/dL, which indicates suboptimal lipid control with existing LLT, particularly in high-risk patients.
first_indexed 2024-04-11T11:43:20Z
format Article
id doaj.art-69925b6384ff421bb822cc436c563de5
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-11T11:43:20Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-69925b6384ff421bb822cc436c563de52022-12-22T04:25:46ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01179e026870910.1371/journal.pone.0268709Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.Lionel PintoMohamed FarghalySasikiran NunnaBadarinath Chickballapur RamachandracharSri Harshadeep ChilukuriAshok Natarajan<h4>Aim</h4>In United Arab Emirates, cardiovascular disease (CVD) is a leading cause of mortality and 22% of CVD deaths are attributable to acute myocardial infarction (MI). Adherence to guidelines for lipid management is incompletely described in the Middle East. This study aimed to characterize lipid lowering therapy (LLT) patterns and the risk of subsequent cardiovascular events (CVEs) in the first year after MI.<h4>Methods</h4>This was a retrospective cohort study using the Dubai Real-World Claims Database, including all patients discharged with MI between January 01, 2015 and December 31, 2018, followed-up until December 31, 2019.<h4>Results</h4>In the first year after MI, 8.42% of 4,595 patients included experienced at least one recurrent MI (rate 6.77 events/100 person-years [PYs]), 2.94% had one revascularization (cumulative rate 0.55 events/100 PYs) and 2.66% had one hospitalization due to unstable angina (cumulative rate 5.16 new events/100 PYs). The majority (60.40%) of the patients presented with LDL-C levels ≥ 70 mg/dL after MI. In the first year after MI, 93.45% of the patients received LLT, mainly high-intensity statin (67.79%); with a minority of patients receiving statin + ezetimibe (4.55%), PCSK9i (0.20%) or ezetimibe alone (0.07%).<h4>Conclusion</h4>Patients hospitalized with MI in Dubai present an increased risk of CVEs in their first-year post-discharge. Majority of the patients presented with LDL-C levels above 70 mg/dL, which indicates suboptimal lipid control with existing LLT, particularly in high-risk patients.https://doi.org/10.1371/journal.pone.0268709
spellingShingle Lionel Pinto
Mohamed Farghaly
Sasikiran Nunna
Badarinath Chickballapur Ramachandrachar
Sri Harshadeep Chilukuri
Ashok Natarajan
Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
PLoS ONE
title Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
title_full Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
title_fullStr Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
title_full_unstemmed Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
title_short Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates.
title_sort lipid lowering therapy patterns and the risk of cardiovascular events in the 1 year after acute myocardial infarction in united arab emirates
url https://doi.org/10.1371/journal.pone.0268709
work_keys_str_mv AT lionelpinto lipidloweringtherapypatternsandtheriskofcardiovasculareventsinthe1yearafteracutemyocardialinfarctioninunitedarabemirates
AT mohamedfarghaly lipidloweringtherapypatternsandtheriskofcardiovasculareventsinthe1yearafteracutemyocardialinfarctioninunitedarabemirates
AT sasikirannunna lipidloweringtherapypatternsandtheriskofcardiovasculareventsinthe1yearafteracutemyocardialinfarctioninunitedarabemirates
AT badarinathchickballapurramachandrachar lipidloweringtherapypatternsandtheriskofcardiovasculareventsinthe1yearafteracutemyocardialinfarctioninunitedarabemirates
AT sriharshadeepchilukuri lipidloweringtherapypatternsandtheriskofcardiovasculareventsinthe1yearafteracutemyocardialinfarctioninunitedarabemirates
AT ashoknatarajan lipidloweringtherapypatternsandtheriskofcardiovasculareventsinthe1yearafteracutemyocardialinfarctioninunitedarabemirates